2 years agoC Difficile treatment. Canadian phase 2 clinical trial, recruiting patients.Canadian phase 2 clinical trial, recruiting patients.
2 years agoStock Market News: Everything You Need To Know Before The Markets Open, Moomoo TradingIPOMarketWatch
1 year agoDr. Nigel McCracken, Ph.D. - Chief Operating Officer, Virax BiolabsProgressPotentialAndPossibilities
3 years agoWALLSTREETBETS: Monday Watchlist Alert BTBT Stock, XELA Stock, SPRT Stock, SOS Stock, NAOV StockVAUGHNSR1
1 year agoSeptember 2023 - Learn How This Company's Phase 3 Drug Could Improve the Mental Health of Patients Suffering from SchizophreniaRedChip
3 years agoNeurometrix: NURO Stock Breakthrough Medical Technology/NanoVibronix NAOV Stock/IMV Stock UpdateVAUGHNSR1
3 years agoNANOVIBRONIX Beats Earnings Expectations (NAOV Stock Showing Signs Of Another Run) CARA Stock UpdateVAUGHNSR1
3 years agoNano Vibronix NAOV Stock Update ( The Buying Pressure Is Building On The Stock ) Stock market TodayVAUGHNSR1
3 years agoWALLSTREETBETS: NAOV Stock Expands PAINSHIELD Relief ( CARA Stock Update ) IS AMC stock Near The EndVAUGHNSR1
3 years agoBionomics IPO Review BNOX Stock Going Public December 16 2021, Initial Public OfferingIPOMarketWatch
5 months agoAZTR Stock - AZITRA 600% - SCALP - TOP gainers LOW float! - Martyn Lucas InvestorMartyn Lucas InvestorVerified
1 year agoRevolutionizing Rare Disease Treatment: Introducing Soligenix's Breakthrough HyBryte™RedChip